The city’s engineer, Roger Hall, said the construction is the final phase of the downtown valve repair project. He added water valves in the downtown area have started to fail over time due to ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

IRVINE, Calif., April 14, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

Image credit: Shutterstock/Steve Cukrov. Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards ...

announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system. Sapien M3 treats patients with symptomatic (moderate-to-severe or severe) mitral regurgitation ...